The irony is that while the U.S. criticizes drug production, it simultaneously reaps financial rewards from its efforts to combat the issue. This creates a cycle where the U.S. is both a critic a

the war on mental health is aggravated by the pharmaceutical industry. Often, profit takes precedence over the well-being of patients. For many, the reliance on medication as the primary treatment option leads to a dangerous cycle of dependency, treating people as consumers rather than complex individuals with diverse needs.